ether has been researched along with salinomycin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antoszczak, M; Brzezinski, B; Huczyński, A; Janczak, J; Stefańska, J | 1 |
Calado, V; da Costa, RP; Ferreira, RG; Monteiro, MA; Pereira, MU; Spisso, BF | 1 |
Feldon, SE; Heffer, AM; Huxlin, KR; Kuriyan, AE; Libby, RT; Phipps, RP; Proaño, J; Roztocil, E; Sime, PJ; Woeller, CF | 1 |
3 other study(ies) available for ether and salinomycin
Article | Year |
---|---|
Synthesis and antimicrobial activity of amide derivatives of polyether antibiotic-salinomycin.
Topics: Amides; Anti-Bacterial Agents; Ether; Hydrogen Bonding; Models, Molecular; Molecular Structure; Pyrans; Staphylococcus aureus; Structure-Activity Relationship | 2012 |
A feasibility study for producing an egg matrix candidate reference material for the polyether ionophore salinomycin.
Topics: Accreditation; Agriculture; Animals; Chickens; Eggs; Ether; Feasibility Studies; Freeze Drying; Ionophores; Pyrans; Reference Standards | 2016 |
The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology.
Topics: Actins; Cell Line; Cell Movement; Collagen Type I; Epithelial-Mesenchymal Transition; Ether; Humans; Pyrans; Retinal Pigment Epithelium; Signal Transduction; Transforming Growth Factor beta; Vitreoretinopathy, Proliferative | 2019 |